β-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis
about
Mst1 and Mst2 kinases: regulations and diseasesMolecular link between vitamin D and cancer preventionG Protein-Coupled Receptors in CancerThe MST/Hippo Pathway and Cell Death: A Non-Canonical AffairNew insights into posttranslational modifications of Hippo pathway in carcinogenesis and therapeuticsThe Good and Bad of β-Catenin in Kidney Development and Renal DysplasiaEmerging role of Hippo pathway in gastric and other gastrointestinal cancersA Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue SarcomasCadherin signaling: keeping cells in touchUsing large-scale genomics data to identify driver mutations in lung cancer: methods and challengesThe molecular rationale of Src inhibition in colorectal carcinomasThe two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatmentThe cellular prion protein PrPc is a partner of the Wnt pathway in intestinal epithelial cellsTargeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer TherapyMouse models of colorectal cancer as preclinical modelsEmerging evidence on the role of the Hippo/YAP pathway in liver physiology and cancerHeterozygous loss-of-function mutations in YAP1 cause both isolated and syndromic optic fissure closure defectsImpact of the physical microenvironment on tumor progression and metastasisAdhesion to fibronectin regulates Hippo signaling via the FAK-Src-PI3K pathway.YES oncogenic activity is specified by its SH4 domain and regulates RAS/MAPK signaling in colon carcinoma cellsThe 1918 Influenza Virus PB2 Protein Enhances Virulence through the Disruption of Inflammatory and Wnt-Mediated Signaling in MiceTRIB2 acts downstream of Wnt/TCF in liver cancer cells to regulate YAP and C/EBPα function.The Hippo transducer TAZ interacts with the SWI/SNF complex to regulate breast epithelial lineage commitment.The YAP1/SIX2 axis is required for DDX3-mediated tumor aggressiveness and cetuximab resistance in KRAS-wild-type colorectal cancer.Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC.TIAM1 Antagonizes TAZ/YAP Both in the Destruction Complex in the Cytoplasm and in the Nucleus to Inhibit Invasion of Intestinal Epithelial CellsRelationship between regulatory pattern of gene expression level and gene function.Integrating Genomics Into Clinical Pediatric Oncology Using the Molecular Tumor Board at the Memorial Sloan Kettering Cancer Center.Crystal structure of TAZ-TEAD complex reveals a distinct interaction mode from that of YAP-TEAD complex.Functional screening identifies miRNAs influencing apoptosis and proliferation in colorectal cancer.Targeting YAP/TAZ-TEAD protein-protein interactions using fragment-based and computational modeling approaches.Yes-Associated Protein Expression Is Correlated to the Differentiation of Prostate Adenocarcinoma.The Hippo pathway in disease and therapy: cancer and beyondKRAS and YAP1 converge to regulate EMT and tumor survivalA novel genome-wide in vivo screen for metastatic suppressors in human colon cancer identifies the positive WNT-TCF pathway modulators TMED3 and SOX12.Addiction to multiple oncogenes can be exploited to prevent the emergence of therapeutic resistance.Identification of genomic alterations in oesophageal squamous cell cancer.A gp130-Src-YAP module links inflammation to epithelial regeneration.The hippo pathway in heart development, regeneration, and diseasesTackling the cancer stem cells - what challenges do they pose?
P2860
Q22001145-1E548784-3197-4DDD-B54D-04039FC5CEA4Q24602044-86BA88FD-78DB-4FA3-9CA3-A22BB274C4D9Q26741203-FFE1F23E-9FA7-4D3C-8615-E17A39999E81Q26744308-5DB8EF88-B9E3-4C70-BAB6-B5B44BFA7B75Q26752756-C9F5E8E8-782F-477C-A6CE-67CBE7DF674FQ26770522-4A77A30C-61E1-4F14-865F-EEB2D0CACB13Q26774473-FC52DAE0-AE97-4A44-9A88-BC6A0F14B20AQ26782842-A9D63767-A9A1-4F60-93C3-CA58832AED19Q26784615-0008DD1A-D4B3-426B-93C8-A511D549125BQ26800833-0E675B1A-3148-4CCA-8D00-B3902CA7B80FQ26853018-5C234EEE-56A6-424E-8B5C-64D6E6E54A18Q27025661-C446E7AA-354A-4995-B6F3-62A77D16A28CQ27306671-97D76740-D8FA-4CA7-931B-D91A51D53718Q28078129-1F950F4C-B11B-4F5F-BE37-576A05B47E5FQ28081871-A2E734F7-944D-482B-9596-01711870F821Q28086905-27CDBFA4-FB9B-4ABB-AE96-44465D50A30FQ28306581-4B954AA4-D84D-4BA5-BCD3-F285108A9D4DQ29299789-D93D3159-B2B7-4626-AE56-D43909BCBBD3Q30278951-42D84878-7053-4390-A3D0-6DA060DD5933Q30371407-EC8A4BF6-5D42-49A1-97E5-F068B4014E4EQ30382370-2AC821DF-2003-4FD6-AE81-8F55D9D4A88FQ33557334-BE58ABB1-B72B-4E2B-B4D6-B9EE182B5F3AQ33570990-C0D9EF7C-0E64-49A9-8BAD-FF2C52B9232FQ33588163-6FB4C5CF-25D9-42BC-BA1E-0F642D30163FQ33614314-01B43792-003E-4ABF-B460-0AEC6D9C22E5Q33658560-1FBE6E63-D0F0-449C-B0BC-0A86060D94B3Q33664296-3EE98CEF-7A64-4C41-B158-87624261FA04Q33677392-28F52D5A-15BC-46AF-850B-D6C53A503CCBQ33700457-1B0A1FBD-9037-4E50-8D48-56770E3619EDQ33706508-CB3EE5E5-D0C0-4AD7-B5EC-6FA2AFC684F5Q33751702-593B88B0-968A-4B7B-831F-5D5E93C4854CQ33925616-C784D647-4725-4135-8A94-B713BD9897BEQ33937666-A36A6F39-9E6F-4450-9C08-A2D0B5085AE1Q33946244-4FE9915A-DF3B-4971-87D6-1BA24FD67678Q33991455-477AA46A-3B65-4F2D-9229-75A6D830E8B9Q34060618-A1FF08B1-CE97-4453-AD0B-12D4A636E7C0Q34412178-A615D5C4-C8E9-4FCA-82E4-F3347DF3BDDAQ34465259-CE70533C-C24D-4F78-A513-D08BF7DE802BQ34470968-3CBF08BC-9BD0-4216-943A-F26D71CFBF1CQ34523263-D2EEA31B-3ADB-4EFF-AEBB-ABC5D1924CAF
P2860
β-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
β-Catenin-driven cancers requi ...... for survival and tumorigenesis
@ast
β-Catenin-driven cancers requi ...... for survival and tumorigenesis
@en
β-Catenin-driven cancers requi ...... for survival and tumorigenesis
@en-gb
β-Catenin-driven cancers requi ...... for survival and tumorigenesis
@nl
type
label
β-Catenin-driven cancers requi ...... for survival and tumorigenesis
@ast
β-Catenin-driven cancers requi ...... for survival and tumorigenesis
@en
β-Catenin-driven cancers requi ...... for survival and tumorigenesis
@en-gb
β-Catenin-driven cancers requi ...... for survival and tumorigenesis
@nl
prefLabel
β-Catenin-driven cancers requi ...... for survival and tumorigenesis
@ast
β-Catenin-driven cancers requi ...... for survival and tumorigenesis
@en
β-Catenin-driven cancers requi ...... for survival and tumorigenesis
@en-gb
β-Catenin-driven cancers requi ...... for survival and tumorigenesis
@nl
P2093
P2860
P50
P3181
P1433
P1476
β-Catenin-driven cancers requi ...... for survival and tumorigenesis
@en
P2093
Anna C Schinzel
Barbara A Weir
Calvin J Kuo
David E Root
Deepak Nijhawan
Diane D Shao
Eric J Schafer
Glenn S Cowley
James T Neal
Jill P Mesirov
P2860
P304
P3181
P356
10.1016/J.CELL.2012.11.026
P407
P577
2012-12-13T00:00:00Z